Circulating fibroblast growth factor (FGF) 21 and adiponectin have been demonstrated to be associated with obesity, insulin resistance (IR), and type 2 diabetes mellitus in cross-sectional [4–7] and prospective studies [8–12]. Here, ADIPOQ is linked to Insulin resistance.